Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Safety and efficacy of mesenchymal stem cells in severe/critical patients with COVID-19: A systematic review and meta-analysis
Weiqi Yao, Haibo Dong, Ji Qi, et al.
EClinicalMedicine (2022) Vol. 51, pp. 101545-101545
Open Access | Times Cited: 21

Showing 21 citing articles:

Fibronectin and vitronectin alleviate adipose-derived stem cells senescence during long-term culture through the AKT/MDM2/P53 pathway
Patcharapa Tragoonlugkana, Chatchai Pruksapong, Pawared Ontong, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Efficacy and safety of mesenchymal stem cells in knee osteoarthritis: a systematic review and meta-analysis of randomized controlled trials
Mu‐Min Cao, Z. W. Ou, Renwang Sheng, et al.
Stem Cell Research & Therapy (2025) Vol. 16, Iss. 1
Open Access
Cancer and COVID-19: unravelling the immunological interplay with a review of promising therapies against severe SARS-CoV-2 for cancer patients
Yan Leyfman, Nancy Emmanuel, Gayathri P. Menon, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 9
Investigational Use of Mesenchymal Stem/Stromal Cells and Their Secretome as Add-On Therapy in Severe Respiratory Virus Infections: Challenges and Perspectives
Sabrina Mattoli, M. Schmidt
Advances in Therapy (2023) Vol. 40, Iss. 6, pp. 2626-2692
Open Access | Times Cited: 8
Immunosuppressive therapy and COVID‐19 infection in patients with NMOSD
Un Wai Choi, Xiwen Ai, Hongyan Li, et al.
Immunity Inflammation and Disease (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 2
Treatment of COVID-19-associated ARDS with umbilical cord-derived mesenchymal stromal cells in the STROMA-CoV-2 multicenter randomized double-blind trial: long-term safety, respiratory function, and quality of life
Alexandre Sitbon, Caroline Hauw‐Berlemont, Miryam Mebarki, et al.
Stem Cell Research & Therapy (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Mesenchymal stem cell therapy for COVID-19 infection
Seyyed Mohammad Matin Alavi-Dana, Yazdan Gholami, Mohammadreza Meghdadi, et al.
Inflammopharmacology (2023) Vol. 32, Iss. 1, pp. 319-334
Closed Access | Times Cited: 6
Efficacy of Wharton Jelly Mesenchymal Stromal Cells infusions in moderate to severe SARS-Cov-2 related acute respiratory distress syndrome: a phase 2a double-blind randomized controlled trial
Cécile Pochon, Caroline Laroye, Antoine Kimmoun, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 4
Stem cell-based therapy for COVID-19
Xiaomei Chen, Bowen Liu, Chao Li, et al.
International Immunopharmacology (2023) Vol. 124, pp. 110890-110890
Open Access | Times Cited: 4
Mesenchymal Stem Cell Priming: Potential Benefits of Administration of Molecular Hydrogen
Mikhail Yu. Artamonov, Tyler W. LeBaron, Felix A. Pyatakovich, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 4, pp. 469-469
Open Access | Times Cited: 1
Controversies regarding transplantation of mesenchymal stem cells
Tsvetelina Velikova, T. Dekova, Dimitrina Georgieva Miteva
World Journal of Transplantation (2024) Vol. 14, Iss. 2
Open Access | Times Cited: 1
Current and Emerging Therapies for COVID-19 in Lung Transplantation
Daniel Friedman, Natasha N. Pettit, Erica L. MacKenzie, et al.
Current Pulmonology Reports (2023) Vol. 12, Iss. 2, pp. 23-35
Open Access | Times Cited: 2
Scale-Up of Academic Mesenchymal Stromal Cell Production
Caroline Laroye, Mélanie Gauthier, Jessica Morello, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 13, pp. 4414-4414
Open Access | Times Cited: 2
Update on the Use of Mesenchymal Stem Cells in the Treatment of Various Infectious Diseases Including COVID-19 Infection
Al-Anazi Khalid A, Al-Ansari Rehab Y
Journal of Stem Cell Therapy and Transplantation (2023) Vol. 7, Iss. 1, pp. 034-042
Open Access | Times Cited: 2
The promising approach of MSCs therapy for COVID-19 treatment
Reza Samanipour, Sara Tabatabaee, Mahsa Delyanee, et al.
Cell and Tissue Banking (2022) Vol. 24, Iss. 3, pp. 597-612
Open Access | Times Cited: 3
Mesenchymal Stem Cells Induce an Immunosuppressive Microenvironment in Pituitary Tumors
Daniel Marrero‐Rodríguez, Victor A Cortes-Morales, Amayrani Cano-Zaragoza, et al.
The Journal of Clinical Endocrinology & Metabolism (2024) Vol. 109, Iss. 11, pp. 2943-2955
Open Access
Stem cell therapy for COVID-19 treatment: An umbrella review
Chaozhi Tang, Arkadiusz Dziedzic, Mahalaqua Nazli Khatib, et al.
International Journal of Surgery (2024) Vol. 110, Iss. 10, pp. 6402-6417
Open Access
Update on the Clinical Applications of Mesenchymal Stem Cells
Al-Anazi Khalid Ahmed
Journal of Stem Cell Therapy and Transplantation (2023) Vol. 7, Iss. 1, pp. 043-064
Open Access | Times Cited: 1
Non-clinical Study of Biodistribution of Human Immature Dental Pulp Stem Cells (Nestacell® Product) Following Intravenous Administration in Mice
Cristiane Valverde Wenceslau, Lionel Fernel Gamarra, Vivian Fonseca Gonzaga, et al.
Research Square (Research Square) (2023)
Open Access
A review of medical image-based diagnosis of COVID-19

Progress in Medical Devices (2023)
Open Access
Mesenchymal stem cells: an early yet promising prospect for Asthma
Mariela Villarreal, Alvaro Moreira
Annals of Translational Medicine (2022) Vol. 10, Iss. 19, pp. 1044-1044
Open Access
Page 1

Scroll to top